Please provide your email address to receive an email when new articles are posted on . We were unable to process your request. Please try again later. If you continue to have this issue please ...
The Interatrial shunt is intended for insignificantly obtrusive delivery to the heart using trans catheter systems. The dime-sized gadget is embedded into the septal wall between the atrial chambers, ...
Tagliati C, Fogante M, Palmisano A, et al. Cardiac masses and pseudomasses: an overview about diagnostic imaging and clinical background. Medicina (Kaunas). 2023; 60: 70.Crossref ...
ANAHEIM, CA—An intracardiac shunt device safely unloads pressure within the left atrium among patients with heart failure and preserved or mildly impaired left ventricular function, according to the ...
Right-to-left shunt through an interatrial communication occurs when pressure in the right atrium is higher than that in the left; it can result in systemic embolism and systemic desaturation. It ...
ATLANTA, GA (May 20, 2022) – Results from early clinical evaluation of the Alleviant System to treat heart failure patients with preserved and reduced ejection fraction (HFpEF and HFrEF) was presented ...
Results from early clinical evaluation of the Alleviant System to treat heart failure patients with preserved and reduced ejection fraction (HFpEF and HFrEF) was presented today as late-breaking ...
Lipomas can occur in the heart, including in the visceral and parietal pericardium. Parietal pericardial lipomas are often clinically mistaken for pericardial cysts. Multiple myocardial lipomas have ...
For well-treated patients refractory to standard medications, the Ventura interatrial shunt was no better than sham in terms of primary effectiveness over nearly 2 years, defined by a hierarchical ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window ATLANTA -- ...
NEW ORLEANS, LA—A novel transcatheter intracardiac shunt device appears to provide sustained clinical benefit at 1 year in heart failure patients with preserved or only mildly reduced ejection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback